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Introduction:  Left  ventricular  reverse  remodeling  (LVRR),  deﬁned  as  reduction  of  end-diastolic
and end-systolic  dimensions  and  improvement  of  ejection  fraction,  is  associated  with  the
prognostic  implications  of  cardiac  resynchronization  therapy  (CRT).  The  time  course  of  LVRR
remains  poorly  characterized.  Nevertheless,  it  has  been  suggested  that  it  occurs  ≤6  months
after  CRT.
Objective:  To  characterize  the  long-term  echocardiographic  and  clinical  evolution  of  patients
with LVRR  occurring  >6  months  after  CRT  and  to  identify  predictors  of  a  delayed  LVRR  response.
Methods:  A  total  of  127  consecutive  patients  after  successful  CRT  implantation  were  divided
into three  groups  according  to  LVRR  response:  Group  A,  19  patients  (15%)  with  LVRR  after
>6  months  (late  LVRR);  Group  B,  58  patients  (46%)  with  LVRR  before  6  months  (early  LVRR);
and  Group  C,  50  patients  (39%)  without  LVRR  during  follow-up  (no  LVRR).
Results: The  late  LVRR  group  was  older,  more  often  had  ischemic  etiology  and  fewer  patients
were in  NYHA  class  ≤II.  Overall,  group  A  presented  LVRR  between  group  B  and  C.  This  was
also  the  case  with  the  percentage  of  clinical  response  (68.4%  vs.  94.8%  vs.  38.3%,  respectively,
p<0.001),  and  hospital  readmissions  due  to  decompensated  heart  failure  (31.6%  vs.  12.1%  vs.
57.1%,  respectively,  p<0.001).  Ischemic  etiology  (OR  0.044;  p=0.013)  and  NYHA  functional  class
<III  (OR  0.056;  p=0.063)  were  the  variables  with  the  highest  predictive  value  for  late  LVRR.
Conclusions:  Late  LVRR  has  better  clinical  and  echocardiographic  outcomes  than  no  LVRR,
although with  a  suboptimal  response  compared  to  the  early  LVRR  population.  Ischemic  etiology
and  NYHA  functional  class  <III  are  predictors  of  late  LVRR.
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Tempo  para  a  remodelagem  inversa  do  ventrículo  esquerdo:  mais  vale  tarde
do  que  nunca
Resumo
Introduc¸ão:  A  remodelagem  inversa  do  ventrículo  esquerdo  (RIVE),  deﬁnida  pela  reduc¸ão  das
dimensões telediastólicas  e  telessistólicas  e  pela  melhoria  da  frac¸ão  de  ejec¸ão,  tem  sido  asso-
ciada às  implicac¸ões  prognósticas  da  terapia  de  ressincronizac¸ão  cardíaca  (TRC).  A  evoluc¸ão
temporal da  RIVE  permanece  um  processo  pouco  caracterizado.  No  entanto,  tem  sido  sugerido
que ocorrerá  num  período  ≤6  meses  após  TRC.
Objetivos:  Caracterizar  a  longo  prazo  a  evoluc¸ão  ecocardiográﬁca  e  clínica  dos  pacientes  (P)
com evidência  de  RIVE,  num  período  >6  meses  após  TRC,  e  identiﬁcar  preditores  de  uma  resposta
de RIVE  tardia.
Métodos:  Cento  e  vinte  e  sete  P  consecutivos,  após  implantac¸ão  bem-sucedida  de  TRC,  foram
divididos em  três  grupos,  de  acordo  com  a  resposta  de  RIVE:  grupo  A,  19P  (15%)  com  RIVE  após
seis meses  (RIVE  tardia);  grupo  B,  58P  (46%)  com  RIVE  antes  dos  seis  meses  (RIVE  precoce)  e
grupo C,  50P  (39%)  sem  RIVE  durante  o  follow-up  (sem  RIVE).
Resultados:  O  grupo  da  RIVE  tardia  era  mais  velho,  tinha  mais  etiologia  isquémica  e  menos
P em  classe  NYHA≥III.  Globalmente,  o  grupo  A  apresentou  um  grau  de  RIVE  entre  os  grupos  B
e C.  O  mesmo  ocorreu  em  relac¸ão  ao  grau  da  resposta  clínica  (68,4  versus  94,8  versus  38,3%,
respetivamente,  p<0,001)  e  às  readmissões  hospitalares  por  descompensac¸ão  da  insuﬁciência
cardíaca  (31,6  versus  12,1  versus  57,1%,  respetivamente,  p<0,001).  A  etiologia  isquémica  (OR
0,044; p=0,013)  e  a  classe  funcional  <III  (OR  0,056;  p=0,063)  foram  as  variáveis  com  maior  valor
preditor  para  a  ocorrência  de  RIVE  tardia.
Conclusões:  A  RIVE  tardia  tem  uma  melhor  resposta  clínica  e  ecocardiográﬁca  do  que  a  ausência
de RIVE,  embora  com  uma  resposta  subótima,  quando  comparada  com  a  populac¸ão  com  RIVE
precoce. A  etiologia  isquémica  e  uma  classe  NYHA  <III  foram  preditores  de  RIVE  tardia.
© 2016  Sociedade  Portuguesa  de  Cardiologia.  Publicado  por  Elsevier  España,  S.L.U.  Todos  os
direitos reservados.
Introduction
Cardiac  resynchronization  therapy  (CRT)  has  become  an
effective  non-pharmacological  treatment  for  patients  with
impaired  left  ventricular  ejection  fraction  (LVEF),  prolonged
QRS  duration  and  New  York  Heart  Association  (NYHA)  func-
tional  class  ≥III  symptoms  of  heart  failure  (HF)  despite
optimal  medical  therapy.  Large  multicenter  clinical  trials
have  shown  that  CRT  can  mitigate  HF  symptoms,  improve
exercise  capacity  and  quality  of  life,  reduce  the  incidence
of  hospitalizations  due  to  HF  and  decrease  mortality.1--4
Most  of  these  beneﬁts  are  thought  to  be  related  to  left
ventricular  (LV)  reverse  remodeling  (LVRR),  a  response  char-
acterized  by  a  reduction  in  LV  end-diastolic  (LVEDD)  and
end-systolic  (LVESD)  dimensions  and  volumes  and  improve-
ment  of  LV  ejection  fraction  (LVEF).5--7 The  time  course
of  this  phenomenon  remains  poorly  characterized.  It  has
been  suggested  that  the  structural  and  functional  changes
associated  with  LVRR  occur  early  after  CRT  and  are  more  pro-
nounced  before  the  six-month  landmark,  a  time  by  which
the  extent  of  reverse  remodeling  has  been  shown  to  pre-
dict  long-term  prognosis  in  these  patients.6--9 Nevertheless,
a  variable  proportion  of  eligible  patients  fail  to  respond  ini-
tially  but  appear  to  develop  LVRR  after  six  months  following
CRT  implantation.  This  population  with  late  LVRR,  who  are
not  included  in  the  already  known  proportion  (around  30%)
of  non-responders  to  CRT,  correspond  to  a  different  spec-
trum  of  individuals  that,  to  the  best  of  our  knowledge,  has
never  been  directly  analyzed  in  a  prospective  study.  To  over-
come  this  limitation,  the  present  study  characterizes  the
timing  of  LVRR  occurrence  and  assesses  the  long-term  echo-
cardiographic  and  clinical  evolution  of  patients  with  LVRR
occurring  >6  months  after  CRT  implantation.  We  also  sought
to  identify  potentially  related  clinical  characteristics  that
might  predict  a  late  response  to  CRT.
Methods
This  is  a  single-center  analysis  of  patients  who  underwent
successful  CRT  device  implantation.  A  total  of  127  consec-
utive  CRT  recipients  were  included  and  patient  data  were
prospectively  collected  in  the  information  system  of  our  car-
diology  department  and  analyzed.  Patients  were  selected
for  CRT  if  they  met  currently  recommended  criteria:
(1)  LVEF  <35%;  (2)  symptoms  of  HF,  deﬁned  as  NYHA  class
II--IV  despite  optimal  medical  therapy;  and  (3)  QRS  duration
≥120  ms.  Patients  were  classiﬁed  as  ischemic  in  the  pres-
ence  of  signiﬁcant  coronary  artery  disease  (>50%  stenosis  of
two  or  more  epicardial  vessels  or  >50%  left  main  or  proximal
left  anterior  descending  coronary  artery  stenosis  on  coro-
nary  angiography  and/or  a  history  of  previous  myocardial
infarction  or  revascularization).  Other  patients  were  clas-
siﬁed  as  non-ischemic.  All  leads  were  placed  transvenously
via  the  subclavian  and  cephalic  route  using  ﬂuoroscopy.
The  right  ventricular  lead  was  positioned  in  the  apex  or
mid  septum.  The  LV  lead  was  placed  with  an  over-the-wire
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system  in  the  posterolateral  or  lateral  tributary  vein  of  the
coronary  sinus  depending  on  the  ability  to  cannulate
the  veins,  pacing  threshold,  or  diaphragmatic  stimulation.
The  standard  settings  included  an  atrioventricular  (AV)
delay  of  100  ms  (sensed)  and  130  ms  (paced),  with  DDD  or
DDDR  mode  and  standard  lower  (50  beats/min)  and  upper
(120--130  beats/min)  pacing  rates.  Extensive  demographic
and  clinical  data,  including  death,  NYHA  class  and  hospital-
ization  for  worsening  HF  or  CRT  dysfunction,  were  collected
from  medical  records.  Transthoracic  two-dimensional
echocardiographic  information  was  assessed  at  baseline,  six
months  after  CRT  device  implantation  and  thereafter  once
a  year  until  the  end  of  follow-up.  In  this  study,  LVRR  was
deﬁned  as  an  increase  >10%  in  LVEF  over  baseline,  combined
with  a  >10%  reduction  in  LVEDD  and  LVESD.  Echocardiogra-
phic  cardiac  structure  and  function  were  assessed  using  a
commercially  available  ultrasound  system  (Vivid  7  and  Vivid
E9;  GE  Vingmed  Ultrasound,  Horten,  Norway)  equipped  with
a  3.5-MHz  transducer.  LVESD,  LVEDD  and  LVEF  were  deter-
mined  according  to  standard  techniques  and  digitally  stored
for  ofﬂine  analysis  in  cine-loop  format.  Interventricular
mechanical  delay  was  calculated  by  pulmonary  and  aortic
pulsed  Doppler  measurement  of  the  difference  in  time  from
QRS  onset  to  onset  of  ﬂow  in  the  pulmonary  and  aortic  out-
ﬂow  tracts,  respectively.  LV  intraventricular  dyssynchrony
was  assessed  ofﬂine  using  a  previously  validated  software
package  (EchoPAC  PC-2D  strain;  GE  Healthcare,  USA).  The
cohort  was  divided  according  to  the  time  course  of  LVRR
response  into  three  groups:  Group  A,  presence  of  LVRR  after
>6  months  (late  LVRR);  Group  B,  with  LVRR  before  6  months
(early  LVRR);  and  Group  C,  without  LVRR  during  follow-up
(no  LVRR).  Follow-up  data  were  obtained  by  review  of
medical  records,  outpatient  clinical  visits,  and  telephone
contact.  Ethical  and  hospital  permission  were  obtained
from  the  appropriate  local  authorities.
Statistical analysis
SPSS  version  21  software  (SPSS  Inc.,  Chicago,  Illinois)
was  used  for  computation.  Data  are  expressed  as  means
±  standard  deviation  for  continuous  variables  and  as
frequencies  and  percentages  for  categorical  variables.
Data  distribution  was  tested  for  normality  using  the
Kolmogorov--Smirnov  or  Shapiro--Wilk  test  as  appropriate.
Missing  patient-level  covariates  were  assumed  to  be  missing
and  no  imputation  was  performed.  Baseline  characteristics
and  outcomes  were  compared  using  the  chi-square  test  or
Fisher’s  exact  test,  when  appropriate,  for  categorical  varia-
bles  and  the  Student’s  t  test  or  the  Mann--Whitney  test  for
continuous  variables.  Univariate  and  multivariate  logistic
regression  analysis  was  used  to  examine  for  potential  pre-
dictors  of  a delayed  LVRR  response.  A  value  of  p<0.05  was
considered  statistically  signiﬁcant.
Results
Patient  baseline  characteristics
Overall,  the  study  population  consisted  of  127  consecutive
patients  who  underwent  successful  CRT  implantation  (aged
63.9±10.7  years,  74.8%  male).  The  mean  follow-up  was
Table  1  Baseline  clinical  and  echocardiographic  characteristics.









Age  (years)  63.9  70±10.7  62.2±11.0  63.3±8.9  0.026
Male (%)  74.8  73.7%  69.0%  82.0%  NS
Etiology (%)
Ischemic  29.9  42.1%  13.8%  44%  <0.001
Non-ischemic  60.6  31.6%  77.6%  52%  <0.001
Mixed 9.5  21.1%  3.4%  4.0%  0.041
Baseline ECG
LBBB  79.5  76.5%  92.6%  76%  0.038
QRS (ms)  170.02  164±26.78  176.29±29.75  164.85±31.83  NS
Sinus rhythm  66.1  57.9%  74.5%  59.6%  NS
NYHA class  ≥III  92.1  78.9%  96.6%  92%  0.021
LVESD (mm)  61.3  70±10.7  62±11.01  63±8.9  NS
LVEDD (mm)  74.5  74±9.4  72±22  77±9.0  0.048
LAD (mm)  47.9  50±10.6  46±9.10  50±12.9  NS
LVEF 24.8%  26.3%  23.7%  25.8%  NS
Pitzalis (ms)  210.8  202±115.5  240±129.5  168±128.6  0.049
IVMD 44.5  47±28.2  51±27.6  37±30.5  NS
LVlat-IVS  delay
(ms)
134.9  130±113.1  119±92.7  135±95.3  NS
IVMD: interventricular mechanical delay; LAD: left atrial diameter; LBBB: left bundle branch block; LVEDD: left ventricular end-diastolic
diameter; LVEF: left ventricular ejection fraction; LVESD: left ventricular end-systolic diameter; LVlat-IVS: left ventricular lateral wall to
interventricular septum; LVRR: left ventricular reverse remodeling; NYHA: New York Heart Association; Pitzalis: LV dyssynchrony by the
Pitzalis method. A mixed etiology was deﬁned as the presence of both ischemic and non-ischemic causes.
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Table  2  Echocardiographic  characteristics  at  follow-up.









LVESD  (mm)  53.53  ±  13.56  53  ±  11.80  49  ±  12.93  63  ±  11.04  <0.001
LVEDD (mm)  69.31  ±  12.45  68  ±  10.05  66  ±  12.33  77  ±  11.12  <0.001
LAD (mm)  47.38  ±  10.76  54  ±  10.04  44  ±  9.26  50  ±  11.22  <0.001
LVEF (%)  38.48  ±  11.04  41  ±  7.73  43  ±  9.35  27  ±  6.32  <0.001
LAD: left atrial diameter; LVEDD: left ventricular end-diastolic diameter; LVEF: left ventricular ejection fraction; LVESD: left ventricular
end-systolic diameter; LVRR: left ventricular reverse remodeling.
48±36  months  (median  37  months).  Baseline  patient  char-
acteristics  are  shown  in  Table  1.  The  majority  of  the  cohort
(60.6%)  had  non-ischemic  cardiomyopathy.
Regarding  differences  between  groups,  late  LVRR
patients  were  older  than  those  in  Groups  B  and  C  (70  years
vs.  62.2  years  vs.  63.3  years,  respectively,  p=0.026)  and
fewer  were  in  NYHA  class  ≥III  (78.9%  vs.  96.6%  vs.  92%,
respectively,  p<0.021).  Group  B,  with  an  early  favorable
CRT  response,  were  younger  than  those  in  Groups  A
and  C  (62.24  years  vs.  70  years  vs.  63  years,  respec-
tively,  p=0.026),  less  often  had  ischemic  etiology  (13.8%
vs.  42.1%  vs.  44%,  respectively,  p<0.001),  included  more
patients  with  left  bundle  branch  block  (LBBB)  (92.6  vs.
76.5  vs.  76,  respectively,  p=0.038)  and  showed  more  LV
dyssynchrony  (240±129.5  vs.  202±115.5  vs.  168±128.6,
respectively,  p=0.049)  as  evaluated  by  the  Pitzalis  method.
Group  C,  the  non-responders,  had  more  patients  with
ischemic  etiology  than  Groups  A  and  B  (44  vs.  13.8  vs.  42.1,
respectively,  p<0.001),  and  had  greater  LVEDD  (77±9.02  vs.
74±9.38  vs.  72±22  mm,  respectively,  p=0.048)  and  less
previous  LV  dyssynchrony  (168±128.6  vs.  202±115.5  vs.
240±129.5  ms,  respectively,  p=0.049),  as  assessed  by  the
Pitzalis  method.  No  statistically  signiﬁcant  differences  were
detected  in  other  electrocardiographic  or  echocardiographic
parameters.
Echocardiographic  and  clinical  changes
after  cardiac  resynchronization  therapy
Comparison  between  groups  of  echocardiographic  data
from  the  last  evaluation  during  follow-up  is  displayed
in  Table  2.  After  CRT  implantation,  LVRR  occurred  in
77  (60.6%)  patients.  The  time  course  of  LVRR  was
different  within  this  population,  with  19  patients  having
late  LVRR  (Group  A),  and  58  patients  having  evidence  of
early  LVRR  (Group  B).  A  signiﬁcant  difference  was  noticed
between  groups  in  terms  of  the  extent  of  LVRR  response.  At
the  last  echocardiographic  evaluation,  compared  to  Groups
A  and  C,  Group  B  presented  lower  LVEDD  (66±12.33  vs.
68±10.05  vs.  77±11.12  mm,  respectively,  p<0.001),  lower
LVESD  (49±12.9  vs.  53±11.8  vs.  63±11.0  mm,  respectively,
p<0.001),  higher  LVEF  (43±9.4  vs.  41±7.73  vs.  27±6.3%,
respectively,  p=<0.001)  and  smaller  left  atrial  diameter
(44±9.3  vs.  54±10.0  vs.  50±11.2,  respectively,  p<0.001).
Regarding  clinical  outcomes,  during  the  mean  follow-up
of  48±36  months,  both  groups  A  and  B  presented  bet-
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Figure  1  Clinical  outcomes  during  follow-up.  LVRR:  left  ven-
tricular  reverse  remodeling.
response  to  CRT,  deﬁned  as  a  sustained  improvement  in
NYHA  functional  class,  was  more  evident  in  group  B  than
in  groups  A  and  C  (94.8%  vs.  68.4%  vs.  38.3%,  respectively,
p<0.001).  Group  B  subjects  were  also  less  often  hospitalized
for  worsening  of  HF  symptoms  (12.1%  vs.  31.6%  vs.  57.1%,
respectively,  p<0.001).  Group  C  showed  higher  cardiac  mor-
tality  compared  to  Groups  A  and  B  (28.6%  vs.  5.6%  vs.  7.3%,
respectively,  p=0.010).
Predictors  of  late  left  ventricular  reverse
remodeling
In  order  to  identify  characteristics  that  might  have  an  impact
on  the  time  course  of  LVRR  after  CRT,  a  logistic  regres-
sion  analysis  was  performed  to  predict  a  late  LVRR  response
(Table  3).  Ischemic  etiology  (odds  ratio  [OR]  0.044;  p=0.013)
and  NYHA  functional  class  ≤II  (OR  0.056;  p=0.063)  were  the
baseline  variables  with  the  highest  predictive  value  for  a
late  LVRR  response  to  CRT.
Table  3  Multivariate  baseline  predictors  of  late  reverse
remodeling  response.
OR  p
Etiology  0.044  0.013
NYHA  class  <III  0.056  0.063
OR: odds ratio; NYHA: New York Heart Association.
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Discussion
The  major  ﬁndings  of  the  present  study,  which  focused  on
the  impact  of  the  time  course  of  LVRR  after  CRT,  are  as
follows:  ﬁrst,  the  majority  of  patients  (60.6%)  presented  evi-
dence  of  LVRR  during  long-term  follow-up;  second,  14.9%
showed  LVRR  only  six  months  after  CRT;  third,  late  LVRR
patients  were  older  and  more  often  had  ischemic  etiology,
and  fewer  were  in  NYHA  class  ≥III;  fourth,  late  LVRR  was
signiﬁcantly  associated  with  better  clinical  and  echocardi-
ographic  outcomes  than  no  LVRR,  although  with  a  suboptimal
response  compared  with  the  early  LVRR  population;  and
ﬁnally,  ischemic  etiology  and  NYHA  functional  class  ≤II  were
independent  predictors  of  late  LVRR.
Several  studies  have  addressed  the  favorable  impact  of
CRT  in  mid-  and  long-term  follow-up,  which  usually  occurs  in
the  ﬁrst  six  months  after  implantation.10--15 The  underlying
mechanism  responsible  for  this  early  improvement  seems
to  be  the  LVRR  response  initiated  soon  after  biventricu-
lar  pacing.5--7 Van  de  Veire  et  al.,  analyzing  49  patients
scheduled  for  CRT,  documented  a  decrease  of  ≥15%  in  LV
end-diastolic  volume  in  47%  of  patients  in  the  ﬁrst  48  hours
after  device  implantation.15 Nina  et  al.,  in  a  review  of
222  consecutive  patients  with  HF  implanted  with  a  CRT  sys-
tem,  reported  a  signiﬁcant  increase  in  LVEF  and  a  decrease  in
LV  end-diastolic  volume  (LVESV)  acutely  after  implantation
followed  by  an  additional  improvement  in  these  parame-
ters  at  six-month  follow-up.16 Wang  et  al.,  in  a  study  of
30  patients  scheduled  for  CRT,  revealed  a  decrease  of  ≥15%
in  LVESV  before  six  months  in  60%  of  the  population.17 Also,
Sanderson  et  al.,  in  a  report  of  30  patients  scheduled  for
CRT,  revealed  an  increase  of  ≥15%  in  LVESV  at  three  months
after  implantation  in  56.7%  of  the  population.18 However,
to  the  best  of  our  knowledge,  no  reports  have  focused  on
LVRR  documented  only  after  six  months.  There  are  no  studies
demonstrating  differences  in  the  long-term  prognosis  of  this
group  compared  with  early  reverse  remodeling.  Pires  et  al.,
in  a  related  study  of  313  HF  patients  from  the  MIRACLE-ICD
trial,  compared  early  (1--3  months)  and  late  (six  months)
clinical  response  after  CRT  and  correlated  it  with  the  pres-
ence  or  absence  of  LVRR,  but  no  signiﬁcant  difference  was
found.19
Despite  being  a  recognized  therapy  with  a  favorable
inﬂuence  on  NYHA  functional  class,  quality-of-life  scores,
rehospitalizations  and  cardiac  death,  there  are  a  signiﬁcant
proportion  of  patients,  estimated  at  30%,  who  are  consid-
ered  clinical  non-responders  to  CRT.20--22 This  population  has
been  extensively  studied  in  previous  reports  and  many  fac-
tors  have  been  proposed  as  potential  contributors  to  a  lack
of  response.  In  this  study  we  found  that  a  delayed  reverse
remodeling  response  after  six  months  shares  some  of  the
variables  that  are  present  in  non-responders.
Patients  with  an  LVRR  response,  in  fact,  also  had  less
conventional  electrical  dyssynchrony  (i.e.  shorter  QRS  inter-
val),  even  though  not  statistically  signiﬁcant,  and  less  severe
mechanical  dyssynchrony  evaluated  by  echocardiography
at  baseline.  Although  the  PROSPECT  trial  showed  modest
sensitivity  and  speciﬁcity  of  echocardiographic  parameters
of  dyssynchrony,23 subanalysis  including  286  patients  from
the  original  PROSPECT  cohort  that  focused  on  three  simple
preprocedural  measures  of  dyssynchrony  reported  a  strong
association  of  their  parameters  with  more  extensive  reverse
remodeling  at  6-month  follow-up.24 LBBB  is  clearly  more
evident  in  early  LVRR  patients.25,26 In  our  study,  Groups  B
and  C  had  a  higher  incidence  of  ischemic  etiology.  Several
previous  studies  have  shown  less  clinical  and  LV  function
improvement  in  ischemic  patients,  probably  due  to  the  pres-
ence  of  myocardial  scar  tissue  in  the  vicinity  of  the  pacing
lead,  limiting  the  extent  of  LVRR  regardless  of  the  extent
of  baseline  dyssynchrony.20--22 Pressure  and  volume  overload
associated  with  LV  involvement  typical  of  HF  patients  leads
to  gradual  ﬁbrosis,  left  atrial  (LA)  enlargement  and  subse-
quently  mitral  regurgitation.  In  this  report,  as  stated  in  other
studies,  an  increased  in  LA  size  was  also  correlated  with  late
or  no  remodeling.27,28
Those  who  responded  early  with  reverse  remodeling  were
more  symptomatic  and  also  had  higher  LV  systolic  and  dia-
stolic  dimensions  at  baseline,  suggesting  that  sicker  patients
have  more  to  beneﬁt  from  CRT.  There  are  other  factors
that  could  help  to  explain  the  difference  in  LVRR.  Iden-
tiﬁcation  and  treatment  of  reversible  causes  in  the  ﬁrst
six  months  after  CRT,  such  as  AV  and  VV  delays  and  sub-
optimal  HF  therapy,  could  transform  a  late  into  an  early
response.  Furthermore,  factors  such  as  the  position  of  the
LV  lead,  optimization  of  device  programming  and  the  pres-
ence  of  rhythm  abnormalities  could  be  related  to  a  delayed
response,  but  were  not  analyzed  in  this  report.
Regarding  clinical  outcomes  during  follow-up,  the
achievement  of  LVRR,  regardless  of  duration  of  CRT,  was
followed  by  symptomatic  and  prognostic  improvement  as
demonstrated  by  a  sustained  decrease  in  NYHA  functional
class,  fewer  hospitalizations  due  to  HF  worsening  and
less  cardiac  deaths  compared  to  non-responders.  Poten-
tial  underlying  factors  could  be  the  restoration  of  inter-
and  intraventricular  synchrony  and  improvements  in  con-
tractility  and  hemodynamics.  These  results  are  in  line  with
previously  described  long-term  positive  outcomes  of  reverse
remodeling  obtained  by  CRT.5--7 However,  analyzing  early  and
late  LVRR  responses,  it  is  clear  that  clinical  beneﬁts  are  more
pronounced  in  the  early  group.  This  could  be  explained,
in  part,  by  the  less  intense  LVRR  response  achieved  in
Group  A,  with  a  smaller  impact  on  LV  dimensions  and  LVEF
compared  with  Group  B.  Nevertheless,  long-term  outcomes
of  late  LVRR  patients  are  signiﬁcantly  better  than  non-
responders.
The  mechanism  of  a  delayed  response  to  CRT  is  complex
and  probably  multifactorial,  with  no  conclusive  explanation
currently  available.  Proper  selection  of  a  suitable  subset
of  patients  is  mandatory,  since  it  appears  that  sicker  HF
patients  may  respond  better  to  CRT.  According  to  our  ﬁnd-
ings,  ischemic  etiology  and  NYHA  functional  class  <III  were
the  only  baseline  features  with  predictive  value  for  the
occurrence  of  a  delayed  LVRR  response  to  CRT.
Limitations
The  present  study  had  some  limitations.  First,  it  was  a
single-center  retrospective  cohort,  albeit  representative
of  real-world  clinical  practice.  Second,  the  deﬁnition  of
LVRR,  also  used  in  previous  studies,30 required  a cut-off  of
10%  reduction  in  LV  dimensions  and  an  increase  of  10%
in  LVEF.  Other  studies  were  stricter  and  used  a  15%
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threshold.29,30 Third,  clinical  response  was  based  only  on
improvement  in  NYHA  class  and  did  not  include  assessment
of  functional  capacity  or  quality  of  life  scores.  Fourth,  echo-
cardiographic  parameters  depend  on  the  operator  and  there
will  always  be  a degree  of  intra-  and  interobserver  vari-
ability.  Fifth,  other  parameters  such  as  position  of  LV  lead,
device  programming,  presence  of  rhythm  abnormalities  and
levels  of  brain  natriuretic  peptide  (BNP)  were  incomplete
and  thus  were  not  considered  for  the  present  study.  Finally,
because  of  the  modest  number  of  patients  studied,  the
current  ﬁndings  regarding  late  LVRR  predictors  need  conﬁr-
mation  in  large-scale  prospective  studies.
Conclusions
Our  data  conﬁrm,  like  other  reports,  that  CRT  is  associated
with  favorable  clinical  and  echocardiographic  responses  dur-
ing  long-term  follow-up.  This  study  is  the  ﬁrst  of  this  kind
to  analyze  the  time  course  of  LVRR  and  to  characterize
the  impact  of  a  delayed  reverse  remodeling  response  in
long-term  follow-up.  Late  LVRR  is  signiﬁcantly  associated
with  better  clinical  and  echocardiographic  outcomes  than
no  LVRR,  although  with  a  suboptimal  response  compared
to  the  early  LVRR  population.  Improvement  in  HF  symp-
toms  and  survival  after  CRT  are  proportional  to  the  timing
and  extent  of  LVRR  response.  Among  all  baseline  parame-
ters  studied,  ischemic  etiology  and  NYHA  functional  class
≤II  were  identiﬁed  as  predictors  of  late  LVRR.  Better  selec-
tion  of  suitable  patients  may  potentially  improve  the  rate  of
early  CRT  responders.
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